LABORATORY URINALYSIS DRUG TESTING

Trade Agreement: NONE
Tendering Procedures: All interested suppliers may submit a bid
Competitive Procurement Strategy: 
Comprehensive Land Claim Agreement: No
Nature of Requirements: 

LABORATORY URINALYSIS DRUG TESTING

DESCRIPTION:

The Department of National Defence has a requirement for the provision of Blind Drug Testing and Safety Sensitive, Cause and Accident/Incident Related and Deterrent Drug Testing for the Canadian Forces Drug Control Program (CFDCP) primarily to detect any presence of prohibited drugs, in addition to Expert Testimony on an “as and when requested” basis.

Canada is seeking to establish a contract for the services as defined in Annex "A", Statement ofWork, from April 1, 2016 to March 31st 2018, with an irrevocable option on the part of Canada to extend the contract period by up to three (3) additional periods of one (1) year each. The services are to be delivered to Canadian Forces units located in different regions throughout Canada. 

REQUIREMENT:

The Contractor must provide Blind Drug Testing, Safety Sensitive, Cause, Control Accident/Incident Related and Deterrent Drug Testing for the CFDCP, in addition to Expert Testimony on an “as and when requested” basis. Testing must be conducted in accordance with the standards established in the Mandatory Guidelines for Workplace Drug Testing Programs (MGWDTP) as issued and amended from time to time by Substance Abuse and Mental Health Services Administration (SAMHSA), United States Department of Health and Human Services.  

The Contractor must maintain physical site security in accordance with SAMHSA guidelines. The Contractor must complete and maintain sample chain of custody documentation asindicated below in paragraph 5.1, using specified screening and confirmatory methods in order to achieve a maximum level of effectiveness and reliability. 

The Contractor must supply upon request the self-contained urinalysis screening cups to be used by the Department of the National Defence for the detection of the following drugs:  Amphetamine, Methamphetamine, Cocaine Metabolite, Marijuana Metabolite, MDA, MDEA, MDMA, Codeine, Morphine, Oxycontin, Oxycodone, Hydromorphone and Hydrocodone. For those with positive results they are shipped to the Contractor’s laboratory for confirmatory.
       
The Contractor must supply upon request the urine collection cups to be used by the Department of National Defence for the collection and shipment of the urine samples to the Contractor’s laboratory for testing.

TRADE AGREEMENTS:

This procurement consists of Medical/Dental Laboratory Services (GSIN: G009F), which are excluded from the application of the Agreement on Internal Trade (AIT) as per Annex502.1B article (f) health services and social services; the North American Free Trade Agreement (NAFTA) as per Annex 1001.1b-2 Services, Class G - Health and Social Services; and the World Trade Organization - Agreement on Government Procurement (WTO-AGP) as per Annex 4 Services.

The requirement is solely limited to Canadian goods and/or services.

MANDATORY TECHNICAL EVALUATION CRITERIA:

At bid closing time, the Bidder must comply with the following mandatory technical criteria and provide thenecessary documentation to support compliance. Any bid which fails to meet the following mandatory technical criteria will be declared non-responsive.  Each criterion should be addressed separately.
 
MT1 At bid closing, the Bidder must hold a validand current Substance Abuse & Mental Health Services Administration (SAMHSA) certification. The Bidder must provide a copy of the valid and current SAMHSA certification. 
 
MT2  At bid closing, the Bidder must demonstrate that they have held a SAMHSA certification for a minimum of three (3) consecutive years within the last five (5) years measured back from the date of Bid Closing. The Bidder must provide a copy of the SAMHSA certification(s) to demonstrate compliance.
 
BASIS OF SELECTION

Lowest Evaluated Price

A bid must comply with the requirements of the bid solicitation and meet all mandatory technical evaluation criteria to be declared responsive. The responsive bid with the lowest Total Evaluated Bid Price will be recommended for award of a contract.

CONTRACTING AUTHORITY:

SUSIE BOUDREAU
Supply Officer
Public Works and Government Services Canada
Acquisitions Branch 
Science Procurement Directorate 
Place du Portage, Phase III, 11C1
11 Laurier Street     
Gatineau, Quebec 
K1A 0S5
Telephone: (819) 956-1689
Facsimile: (819) 997-2229
E-mail address:              Susie.Boudreau@tpsgc-pwgsc.gc.ca

All enquiries must be submitted in writing to the Contracting Authority no later than ten (10) calendar days before the bid closing date.
Delivery Date: Above-mentioned

The Crown retains the right to negotiate with suppliers on any procurement.

Documents may be submitted in either official language of Canada.